Capricorn Fund Managers’s BeOne Medicines Ltd ONC Stock Holding History

Capricorn Fund Managers’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,735	Closed	-$2.47M	–	94
2023 Q3	$2.47M	Buy	+13,735	New	+$2.72M	0.86%	37
2023 Q2	–	Sell	-7,102	Closed	-$1.53M	–	120
2023 Q1	$1.53M	Buy	+7,102	New	+$1.7M	0.47%	61
2022 Q3	–	Sell	-19,800	Closed	-$3.21M	–	125
2022 Q2	$3.21M	Buy	19,800 +17,392	+722%	+$2.72M	0.58%	45
2022 Q1	$454K	Buy	+2,408	New	+$512K	0.11%	82

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Capricorn Fund Managers's ONC Position: Q4 2023 in Review

Capricorn Fund Managers sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 13,735 shares — an estimated $2.47M sold.

Capricorn Fund Managers first reported a position in ONC in Q1 2022 and held it in 4 quarters. The position peaked at $3.21M in Q2 2022. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

Capricorn Fund Managers reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
Capricorn Fund Managers sold 13,735 BeOne Medicines Ltd shares in Q4 2023, an estimated $2.47M.
Capricorn Fund Managers first reported a position in BeOne Medicines Ltd in Q1 2022 and held it in 4 quarters.
Capricorn Fund Managers's BeOne Medicines Ltd position peaked at $3.21M in Q2 2022.
204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Capricorn Fund Managers's 13F filing for Q4 2023, filed 10 Jan 2024.